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INTRODUCTION 
 
Nature has many remedies for our ailment, nature has created 
innumerable  plants, metals, poisonous substances, minerals, organic 
substances and products of animal origin. 
 
The science of medicine is of fundamental importance to man’s well 
being and his survival. So it must be  originated with man and developed 
gradually as civilization advanced. 
 
Siddha system is perhaps the earliest medical science that laid stress on 
positive health, a harmonious blending of physical, mental, social and spiritual 
welfare of an individual. 
 
Appreciation and appropriate of siddha science and system is sure to 
give us a happy, healthy and harmonious life. 
 
Siddhars have selected things from the nature which can render relief to 
innumerable ailments of mankind suffered and its suffering. Siddha system of 
medicine is ingrained in Tamilians. We grew up with this medical system. 
 
Apart from the usage of herbs it could be asserted that the siddhars 
were pioneers in the use of metals and minerals in the treatment of diseases. 
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Siddha system has its own well-developed chemistry with thousands of 
mineral and metallic preparations. The siddha system is a wonderful treasure 
house that has immense potentialities to solve any medical problem. 
 
Any effective remedy must be safe in usage, easy to administer, 
available with easy access and cheap enough to only through the siddha 
system of medicine since it is already having its roots in the rural areas and 
people are already practicing home remedies.  
 
Siddha literature is brilliant in its evolution of a rest cycle of original 
occult knowledge dealing with the essentials of religion and science in 
consonance with the principle of the theoretical and practical knowledge. 
 
We are now  witnessing a renaissance in siddha medicine and indeed in 
all the natural system of medicine such as Ayurvedha, Unani, Chinese 
traditional medicine etc. disease which cannot be satisfactorily managed by 
modern medicine are successfully treated by this natural system of medicine. 
However, there successes are readily questioned by the modern 
science. It is alleged that even if this treatment is successful some days used in 
the siddha system are toxic and dangerous for use. The fact that the siddha 
physicians use plants such as Etti, Serankottai etc., and chemical such 
mercury, arsenic, cinnabar etc., which are toxic in raw farm, add weightage to 
this argument. 
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The untrue belief of toxicity posing a major obstacle to the renaissance 
of siddha medicines. The explanations such as raw forms are purified  to 
remove toxicity and the drugs are used with established safety from time 
immemorial are not bought by modern science. 
 
The  efficacy of many siddha preparations have been established but 
their safety are not the siddha physicians should embrace ourselves the siddha 
drugs are indeed safe and we should do this by using well established, modern 
and scientific methods. Veera chenduram a widely used siddha medicine, 
contains perchloride of mercury found in mountains naturally. This is used for 
the treatment of several ailments.  
 
This toxicity study of veera chenduram just a small step in the right 
direction of establishing the safety of siddha drugs. This is dedicated to the 
glory of siddha system. 
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AIM & OBJECTIVES 
  
Veeram is one of the pancha soodham in Siddha system. It is used for 
many diseases in Siddha system of medicine. 
 
 AIM 
 The aim of the dissertation is toxicity studies of Veera Chenduram. 
 
 OBJECTIVES 
 The toxicity of Veera chenduram has been evaluated in the following aspects:            
1. Collection and Identification of the test material 
2. Purification of the raw drug Veeram. 
3. Preparation of the Veera chenduram 
4. XRD study of the Veeram (impure), purified Veeram and 
Veera chenduram 
5.Toxicological studies of the veera chenduram 
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MODERN ASPECT 
MERCURIC CHLORIDE 
Synonyms 
 
Mercury bichloride; corrosive sublimate; mercury (II) chloride; mercury 
perchloride  
 Molecular Weight: 271.52  
Chemical Formula: HgCl2 
Mercuric chloride exists in the film of heavy, colourless masses of 
prismatic crystals or as a white crystalline powder.  It has a styptic, nauseous, 
metallic taste.  It is soluble in eighteen parts of cold water and three parts of 
boiling water.  It is readily soluble in alcohol (90 percent) ether and glycerin and 
is very soluble in solutions of alkaline chlorides.  On account of its antiseptic 
properties it is largely used in medicine as well as in taxidermy.    
Physical and Chemical Properties 
Appearance :  
White crystals or powder.  
Odour:  
Odourless.  
Solubility:  
7.4g in 100g of water.  
Specific Gravity:  
5.4  
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pH:  
3.2 (0.2 M solution)  
Boiling Point:  
  302C (576F) Sublimes.  
Melting Point:  
  276C (529F) Sublimes.  
Vapor Density (Air=1):  
  8.7  
Vapor Pressure (mm Hg):  
1 @ 136.2C (277F)  
 Stability and Reactivity 
Stability 
  Stable under ordinary conditions of use and storage. Slowly 
decomposes to metallic Hg in the presence of organic matter and sunlight, and 
becomes volatile at 300C (572F).  
 Incompatibilities 
  Reacts violently with potassium and sodium. Incompatible with many 
compounds: formates, sulfites, phosphates, albumin, ammonia, gelatin, 
carbonates, hypophosphites, sulfides, alkalis, alkaloid salts, lime water, 
antimony and arsenic, bromides, borax, reduced iron, copper, iron, lead, tannic 
acid and vegetable astringents.  
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BORAX 
Other Names: 
 Borax decahydrate, Boricin, Dinatrium fetraborat decahydrat, Disodium 
tefraborate decahydrae, Gerstley borate, sodium biborate decahydrate, 
solubor. 
 Borax is an important boron compound, a mineral and a salt of boric 
acid.  It is usually a white powder consisting of soft colorless crystals that 
dissolve easily in water.  Borax is used in detergents and cosmetic as an 
igredients 
 Systematic name  : Sodium tetraborate decahydrate 
 Molar formula  : Na2B40710H2O 
 Molar Mass   : 381.37 g/mol 
 Appearance   : White solid 
Sources: 
 It occurs naturally in evaporate deposits produced by the repeated 
evaporation of seasonal lakes.  The most commercially important deposits are 
found in Turkey, California and other locations in the American South West.  
The Atacama Desert in chile and in Tibet.  Borax can also be produced 
synthetically from other boron compounds. 
Properties: 
 Density and phase  : 1.73g/cm3, Solid 
 Solubility in water  : 5.1g/100ml(20oC) 
 Melting Point   : 75oC 
 Boiling Point   : 320C 
 Crystal Structure  : Monoclonic 
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TOXICOLOGICAL ASPECT  
SIDDHA ASPECT 
uQvfR<Sg<!GxqG{l<;!
! -K! fQiqz<! Ougligg<! gjvBl<! ke<jlBjmbK/! ! -K!
dm<ogi{<mUmOeOb! GVkqObiM! gzf<K! uqmk<jk! lqg! Ouglig!
uqjtuqk<KuqMl</! ! -K! hqxjvg<ogiz<Zl<! ohiVm<Ml<,! kx<ogijz!
Hiqf<Kogit<tUl<!hbe<hMk<KuK{<M/!
GxqG{l<;!
! -jk! dm<ogi{<miz<! uibqz<! yVujgg<! gtql<Hs<! Sju!
d{<miGl</!!Uibqz<!fQ'Xl</!!uib<!H{<{igq!uQr<Gl</!!oki{<jmBl<,!
Nlisbl<!biUl<!uQr<gqh<!H{<{iGl</!!uif<kqBl< ,!lzOhkqBl<, GVkqg<!
gpqs<sZl<! d{<miGl</! ! ws<sqjzg<%m! uqPr<g! Lcbikhc!
oki{<jmbqz<!uzq!Wx<hMl</!!Lgl<!uQr<gquqMl</!!dml<hqZt<t!Okiz<!
LpuKl<! hm<jm! hm<jmbig! ouck<Ks<! sqjz! fQi! ucBl</! ! Hg<gl<,!
uqzi!Lkzqb!-mr<gtqz<!nkqg!OfiUl<,!Gjms<sZL{<miGl</!!nkqg!
fQI!Oum<jg,!uqg<gz< ,!&Is<js,!lbg<gl<,!uzq!Lkzqbe!d{<miGl</!!
-OkiM!siUl<!d{<miGl</!
! ! uQvfR<S!LxqU!
! Ljxbigs<!su<uQv!olib<Gpzib<!ogi{<miz<!
! sqXofVR<sqx<!siX{<{k<!kQVl<!.!njxbg<Ogt<!
! fQzqOu!viGOl!ofb<s<sm<cs<!sixiOl!
! hizq!oke<er<!gt<Tl<!hgI!
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 n{<mk<kqe<!ou{<gVju!biuqe<hi!zqx<gzf<)K*!
 d{<Muv!uQv!EvlgZr<!.!g{<mxquib<!
! W{x<!ogicOb!bqtfq!vVf<kqcEl<!
! li{h<ohVjl!uPk<K/!
ohipqh<Hjv;!
!!Okjubie!ohiVm<gt<!;!!
! ! ! sqX!ofVR<sqs<siX,!
! ! ! fQzqOuIh<hm<jm,!
! ! ! ofb<s<sm<cg<gQjv,!
! ! ! oke<er<gt</!
osb<Ljx;!!
2/ 31!lq/zqm<!sqX!ofVr<sqg<!six<jxg<!gijzbqZl<!lijzbqZl<!
Gck<Kuv!Ou{<Ml</!
3/ fQzq! OuIh<hm<jmjb! ouf<fQIuqm<M! njvk<K! yV!
S{<jmg<gib<! uQkl<! wMk<K! 91! lq/zqm<! -t! ouf<fQiqz<!
gjvk<Kg<!gijzbqZl<!lijzbqZl<!Gck<KuvOu{<Ml</!!!
4/ 31! lq/zqm<! ofb<s<sm<cg<gQjvs<six<jx! gijzbqZl<!
lijzbqZl<!Gck<Kuv!Ou{<Ml</!
5/ oke<er<gt<!nVf<kq!uvzil</!!!!
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MODERN ASPECT 
Inhalation 
 Cause irritation to the respiratory tract. Symptoms include sore throat, 
cough, pain, tightness in chest, breathing difficulties, shortness of breath and 
headache. Pneumonitis may develop. Can be absorbed through inhalation with 
symptoms to parallel ingestion. Vapor inhalation can burn the mucous 
membrane of the nose and throat.  
Ingestion 
 Cause burning of the mouth and pharynx, abdominal pain, vomiting, 
corrosive ulceration, bloody diarrhoea. May be followed by a rapid and weak 
pulse, shallow breathing, paleness, exhaustion, central nervous system 
problems, tremors and collapse. Delayed death may occur from renal failure.  
Skin Contact 
 Cause irritation and burns to skin. Symptoms include redness and pain. 
May cause skin allergy and sensitization.  
Eye Contact 
 Cause irritation and burns to eyes. Symptoms include redness, pain, and 
blurred vision; may cause serious and permanent eye damage.  
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Teratogen 
  Can damage the developing fetus and decrease fertility in males and 
females.  
Reproductive Toxicity 
 All forms of mercury can cross the placenta to the foetus, but most of 
what is known has been learned from experimental animals. 
Aggravation of Pre-existing Conditions  
 Persons with nervous disorders, or impaired kidney or respiratory 
function, or a history of allergies or a known sensitization to mercury may be 
more susceptible to the effects of the substance.  
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veeram Before Purified veeramAfter purified 
 
 
 
Venkaram Before purified Venkaram After Purified 
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MATERIALS AND METHODS 
Procurement and identification of the Veeram 
Procurement of the Veeram 
 The drug was collected from the local market in Chennai. 
Identification of Veeram 
 The Veeram was identified as mercuric Chloride by the base of its 
physical properties in chemical laboratory. 
Purification of the Veeram  
 The purification method of Veeram was selected in accordance with the 
reference made in the Gunapadam Thathu Jeeva Vaguppu.  
 
 1 palam of camper was dissolved in tender coconut and kept in a mud 
pot.  1 palam was suspended over the contents of pot and heated for ½ hour. 
 
Preparation of Veera Chenduram 
 1 palam  of veeram and venkaram was taken in a mud pot.  Fried it up to 
chenduram consistency  
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X- RAY POWDER DIFFRACTION (XRD) 
The XRD analysis of the drug Veera chenduram was done in 
Department of Nuclear physics, University of Madras. 
The powder method of diffraction was devised independently by Debye 
and Scherrer. Powder diffraction method involves the diffraction of 
monochromatic X- rays by a powder specimen. Monochromatic usually means 
a strong Kα characteristic component of the filtered radiation from an X- ray 
tube operated above the Kα excitation potential of the target material. 
 Selection of Kα renders the incident beam to be a highly 
monochromatised one. The focusing monochromatic geometry results in 
narrower diffracted peaks and low background at low angles. The sample is 
mounted vertically to the Seemann- Bohlin focusing circle with the scintillation 
counter tube moving along the circumference of it. It is possible to record the 
diffracted beam from 2 to 160 degrees. The diffractometer is connected to a 
computer for data collection and analysis. The scintillation counter tube can be 
moved in step of 0.01 degree by means of a stepper motor and any diffracted 
beam can be closely scanned to study the peak profile.    
Identification of the material 
 The powder diffraction of a substance is characteristic of the substance 
and forms a sort of fingerprint of the substance to be identified. The peaks of 
the X-ray diffraction pattern can be compared with the standard available data 
for the conformation of the structure. For the purpose of comparison, many 
standards are available, some of which are, Willars hand book, Joint 
Committee on Powder Diffraction Standards (JCPDS) Pepdfwin and National 
Bureau of Standards. 
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TOXICITY STUDIES 
ACUTE TOXICITY STUDY 
 
EXPERIMENTAL STUDY 
VEHICLE USED: 
                   Water was used as vehicle. Starting dose was 5mg/kg. And the 
subsequent doses are 10, 50, 100, 250, 500, 1000 2000 and 4000mg/kg p.o. 
used in this study. 
ACUTE TOXICITY STUDY 
Veera chenduram suspended in water was administered to the groups of 
wistar rats in a single oral dose by gavage using a feeding needle. The control 
group received an equal volume of the butter vehicle. Ten females and ten 
males were used for each dosage level. The principles of laboratory animal 
care were followed. Observations were made and recorded systematically 1, 2, 
4 and 24 hr after substance administration. The visual observations included 
skin changes, mobility, aggressively, sensitivity to sound and pain, as well as 
respiratory movements. They were deprived of food, but not water 16–18 hr 
prior to the administration of the test suspension. Finally, the number of 
survivors was noted after 24 hr and these animals were then maintained for a 
further 13 days and observations made daily. At the conclusion of the 
experiment, all surviving animals were sacrificed with anesthetic ether and their 
organs such as liver, lungs, heart, spleen, adrenals, kidneys, testes and ovaries 
were excised and weighed. The pathological observations of these tissues 
were performed on gross. The toxicological effect was assessed on the basis of 
mortality, which was expressed as LD50.  
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Statistical analysis 
Either the analysis of variance (ANOVA) or Dunnet multiple comparison 
test (Instat-3 computer program) was employed to analyze the results 
statistically. A statistical comparison was carried out using the Dunnnet Multiple 
comparison Test. All values were expressed as back transformed mean ±S.D. 
Differences below the probability level of 0.01 were considered statistically 
significant. 
SUBACUTE TOXICITY 
 Three groups of 6 rats received Veera chenduram by intra-gastric 
gavages at the dose of 50mg/kg, 100mg/kg, 200mg/kg body weight every for 
28 days.  During the period of administration the animals were weighed and 
food and water intake were monitored. After 28 days all surviving animals were 
fasted overnight. Animals were sacrificed by decapitation and blood samples 
were collected into heparinized tube for hematological parameters and non-
heparinized centrifuge tubes.  The Brain, Lung, Liver, Pancreas, Spleen, 
Stomach, Testes, Ovary, Heart and Kidney were collected and weighed.  
 
Biochemical estimations  
The serum separated was analysed to evaluate the liver enzymes. Total 
protein, Albumin, Globulin, Blood glucose, Total Cholesterol, HDL, LDL, VLDL, 
Total Bilirubin, Direct Bilirubin, Indirect Bilirubin, SGOT, SGPT, ALP, γ-Glutamyl 
Transferase, Creatinine, Urea, Uric Acid, Sodium, Potassium, Chloride.  
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Haematological assay  
Blood samples collected in the heparinized tubes were used to 
investigate TRBC, Hb, PCV, MCV, MCH, RDW, ESR, Platelets, TLC and DLC 
using the standard method.  
Histopathological study  
Histopathological investigation of the vital organs were done The organ 
pieces  (3-5  µm thick) were fixed in 10% formalin for 24 hr and washed in 
running water for 24 hr. Samples were dehydrated in an auto technicon and 
then cleared in benzene to remove absolute alcohol.  Embedding was done by 
passing the cleared samples through three cups containing molten paraffin at 
50°C and then in a cubical block of paraffin made b y the “L” moulds. It was 
followed by microtome and the slides were stained with Haematoxylin-eosin.   
Statistical analysis  
Values were expressed as mean  ± SD. The statistical analyses of 
variance were done by ANOVA followed by the dunnet test. 
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RESULTS AND OBSEVATIONS 
 
XRD study of the Veeram (impure), purified Veeram and Veera chenduram 
 
The sample of Veeram is matched with standard graph mercuric 
chloride.  
 
The sample of venkaram is matched with standard graph of sodium 
biborate. 
 
The sample of purified venkaram is matched with standard graph of 
tincalconite 
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Toxicological studies of the Veera chenduram 
Acute  
Death was recorded during the treatment period in treated groups given 
1g/kg of Veera chenduram orally.   The treatment of Veera chenduram on rats 
possess significant changes in general behavioural pattern and produced major 
signs of toxicity from the dose level of 500mg / kg and above in an acute 
exposure. The animals showed changes in general behaviour other 
physiological activities like giddiness, sniffing, aggressiveness, tachypnoea, 
convulsion finally at the dose level of 1g/kg.  
Sub acute 
In the sub acute toxicity study, after 28 days of alternate day treatment 
of veera chenduram in single oral dose showed insignificant body weight 
changes (Table-1) during the experimental period. But significant (P<0.01) 
increase in food intake was observed in all the groups after one week of drug 
treatment (Table-2). There was a gradual decrease in water consumption was 
observed in all the groups throughout the study period (Table-3). 
 
In the hematological parameters, there was a marked increase in TLC 
and RDW was observed and also decrease in haematocrit value (P<0.01) was 
noted in the animals given 50mg/kg dose of veera chenduram (Table-4). 
 
 
 
 
 
 27 
Similarly, from the biochemical analysis, the ALP, SGOT, SGPT levels 
were decreased significantly (P<0.01) in all the dose treated groups but there 
was no major modifications in the other biochemical parameters. A fall of blood 
glucose level was observed in the groups treated with 50mg/kg dose of veera 
chenduram (Table-5). 
Table-6 shows that the urea, sodium concentrations are drastically 
increased (P<0.01) in the entire dose treated groups with respect to control.  
The results of urine analysis indicate that the urine volume is gradually 
decreased in the dose dependent manner after veera chenduram treatment. In 
the same manner there was a slight alterations was observed in PH. The colour 
intensity of the urine is increased on the basis of drug dose range. In the urine 
collected from the 200mg/kg veera chenduram treated group few RBC, Pus 
and epithelial cells were seen (Table-8).  
The isolated vital organ weights were changed significantly after 28 days 
of veera chenduram treatment in experimental animals. Particularly, liver, lung, 
spleen and stomach weights were decreased (Table-9). 
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HISTOPATHOLOGICAL CHANGES (200mg dose level) 
1. In brain :  
oedema, 
microcytic degeneration. 
Asterocytic proliferation 
2. In Lungs: 
Emphysematous changes 
3.  In Liver: 
Inflammatory cells around portal triad. 
Hepatocytes nuclei shows nuclear damage. 
4. In Stomach: 
Congestion and erosion superficially. 
5.  In Kidney: 
Marked tubular necrosis 
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Table-1 Incremental dose finding experiment and its Signs of Toxicity after oral administration of Veera Chenduram in rats. 
No Treatment Dose 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. I 5 + - - + - + - - - - - - - - - - - - - - 
2 II 10 + - - + - + - - - - - - - - - - - - - - 
3 III 50 + + - + - + - - - - + - - - - - - - - - 
4 IV 100 + + - + - + - - - - + - _ + - - - - + - 
5 V 250 + + + + - + - - - - + - _ + - - - - + - 
6 VI 500 + + + + - + - + - - + + + + - + - - + - 
7 VII 1000 + + + + - + + + + - + + + + - + + - + + 
8 VIII 2000 + + + + - + + + + + + + + + - + - - + + 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. Increased Motor Activity 
8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 
15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Number of Deaths (Mortality) 
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Table 1. Body wt (g) of albino rats exposed to Veera chenduram for 4 weeks. 
Days Dose 
(mg/kg/day) 1 7 14 21 28 
Control 103.33±12.11 103.33±10.32 106.66±12.11 101.66±11.69 119.16±10.20 
50 106.66±8.16 109.96±9.17 105±8.2 105±10.48 115±10.48 
100 106.66±12.11 112.5±10.84 105±10.48 110.83±10.20 110±12.64 
200 110.83±10.2 112.5±10.84 109.16±10.2 116.6±7.52 120±5.47 
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Table 2. Food (g/day) intake of albino rats exposed to Veera chenduram for 4 
weeks. 
Days(gms/rats) Dose 
(mg/kg/day) 1 7 14 21 28 
Control 40.66±2.73 44.16±2.85 45.33±2.94 43.16±2.48 48.33±2.58 
50 38.66±2.65 43.16±5.26 38±2.09** 43±2.68 44.83±2.48 
100 35.33±2.06 39.5±4.08* 32±2.89** 39.83±2.13 38.66±2.16** 
200 30.33±1.86** 41±3.68 31.33±2.42** 39.83±2.40 40.5±3.88** 
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Table 3.Water(ml/day)intake of male and female albino rats exposed to Veera 
chenduram for 4 weeks. 
Dose 
(mg/kg/day) 
Days(ml/rat) 
 1 7 14 21 28 
Control 80.33±2.42 60.33±2.42 60±2.09 53.10±2.48 50.33±1.86 
50 73.66±2.25** 65±1.67** 50.5±1.76** 49.8±2.04NS 45.5±3.14** 
100 70±2.09** 68.66±2.33** 49.66±1.36** 40.16±1.32** 44.84±2.04** 
200 71.66±2.25** 69.83±2.04** 43.5±2.66** 50.33±2.42NS 45±1.67** 
 
0
10
20
30
40
50
60
70
80
90
1st day 7th day 14th day 21st day 28st day
Control
Group I
Group II
Group III
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Table 4. Hematological parameters after 4 weeks treatment with the Veera chenduram 
Parameter Control 50mg/kg 100 mg/kg 200 mg/kg 
Red blood cell 
(million/cumm) 
7.84±0.54 7.98±0.33 7.98±0.26 8.06±0.31 
HB gm/dl 50.26±1.09 50.51±0.53 50.03±0.34 50.31±0.36 
Leukocyte 
(x106/cumm) 
10427±601.34 18251±1134** 23566±1398** 27816±1424** 
Platelets/µl 1149±148.20 1210±77.03 1139±84.02 1067±59.76 
RDW 14.45±0.97 17.36±0.69** 16.05±0.68** 14.01±0.64** 
MCV(fl) 61.7±0.36 54.50±0.71 55.65±4.72 56.14±4.74 
DLC(%) 
N 6±1.54 7.16±0.98 6.5±1.04 6.5±1.04 
L 90.33±1.63 90.66±1.75 90.83±1.94 90.33±1.63 
M 2.5±0.54 0.5±0.54 1.66±0.81 1.5±0.54 
E 1.160.75 1.16±0.98 1±0.63 1.66±1.03 
B 0±0.00 0.5±0.54 0±0.00 0±0.00 
ESR(mm/hr) 1.33±0.51 1.33±0.51 1±0.00 1±0.00 
PCV(%) 48.42±3.47 43.47±2.48** 44.33±2.39* 45.32±3.57 
MCH (pg) 19.45±0.19 19.44±0.74 18.84±0.71 18.98±0.93 
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 Table 5. Effect of treatment with Veera chenduram biochemical parameters. 
LFT 
Parameter Control 50mg/kg 100 mg/kg 200 mg/kg 
Total Bilirubin(mg/dL) 0.21±0.04 0.25±0.05 0.16±0.05 0.18±0.07 
Bilirubin Direct(mg/dL) 0.1±0.00 0.1±0.00 0.11±0.04 0.08±0.04 
Bilirubin Indirect 
(mg/dL) 
0.11±0.04 0.15±0.05 0.11±0.04 0.08±0.07 
ALP (U/L) 230.5±9.75 295.66±12.86** 269±8.60** 244.83±13.36 
SGOT (U/L) 178.83±27.6 146.5±11.67** 144.16±14.67** 127.16±10.64** 
SGPT(U/L) 59.66±7.86 22.83±6.30** 13.83±1.72** 10.66±2.16** 
Total Protein(g/dl) 8.35±0.49 8.01±0.38 6.1±0.60 5.38±0.64 
Albumin(g/dl) 3.1±0.32 3.35±0.51 2.85±0.25 2.53±0.33 
Globulin(g/dl) 5.25±0.70 4.5±0.84 3.25±0.37 2.85±0.31 
GGT(U/L) 7.9±0.35 9.8±0.60 9.30±0.41 8.2±0.28 
Blood glucose(mg/dl) 105.16±3.48 72.5±10.61** 109.83±5.77 98.33±9.41 
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Table-6 RFT 
Parameter Control 50mg/kg 100 mg/kg 200 mg/kg 
Urea(mg/Dl) 59.46±2.57 176.85±12.75** 208.16±12.27** 240.16±10.32** 
Creatinine (mg/dL) 0.65±0.10 2.53±0.48 2.96±0.14 3.13±0.25 
Uric acid (mg/dL) 1.41±0.37 1.8±0.17 1.48±0.22 1.11±0.08 
Na (m.mol/Lr) 130.76±11.45 147.16±9.26** 145.5±9.37** 148.66±14.16** 
K (m.mol/Lr) 4.6±0.22 7.53±0.85 6.81±0.78 6.03±0.59 
Cl (m.mol/Lr) 110.16±9.02 104±5.32 109.5±7.81 114.83±9.04 
 
Table-7 LIPID PROFILE 
Dose (mg/kg) Control 50mg/kg 100 mg/kg 200 mg/kg 
Total cholestrol(mg/dL) 37.5±4.08 42.66±3.55 40±1.41 37.33±3.77 
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Table-8 URINE ANALYSIS 
Parameters Control 50mg/kg 100 mg/kg 200 mg/kg 
Volume 2.8ml/24hr 1.8ml/24hr 1.2ml/24hr 1.4ml/24hr 
Colour Straw Yellow Orange Yellow Orange Reddish 
Orange 
Transparency Clear Clear Clear Clear 
Specific gravity 1.010 1.010 1.010 1.010 
PH 7.2 >7.8 >8.0 >8.0 
Protein Nil Nil Nil Nil 
Glucose Nil Nil Nil Nil 
Bilirubin -ve -ve -ve -ve  
Ketones -ve -ve -ve -ve 
Blood Absent Absent Absent Present 
Urobilinogen Normal Normal Normal Normal 
Pus cells Nil 3-4cells/HPF 5-6cells/HPF 5-6cells/HPF 
RBCs Nil Nil Present  Present 
Epithelial cells 1-2cells/HPF 1-2cells/HPF 2-3cells/HPF  2-3cells/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen Bacteria seen 
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Table 9. Effect of oral administration of a Veera chenduram on organ weight 
Parameter Control 50mg/kg 100 mg/kg 200 mg/kg 
Liver (g) 5.34±0.07 5.61±0.14** 4.48±0.26** 4.3±0.15** 
Heart (g) 0.62±0.04 0.55±0.02 0.48±0.08 0.46±0.03 
Lung (g) 1.60±0.07 1.10±0.14** 1.67±0.20 1.39±0.09 
Spleen (g) 0.67±0.04 0.47±0.02 0.15±0.03** 0.24±0.04** 
Ovary (g) 2.04±0.05 2.04±0.10 2.09±0.11 2.55±0.42** 
Testes (g) 1.34±0.12 1.09±0.09* 1.23±0.07 1.24±0.07 
Brain (g) 1.51±0.08 1.47±0.11 1.52±0.04 1.65±0.11 
Kidney (g) 0.64±0.05 0.80±0.08 0.79±0.07 0.73±0.07 
Stomach (g) 1.48±0.10 1.07±0.07** 1.06±0.08** 1.12±0.07** 
**P<0.01; *P<0.05. N=6 Values are mean ± S.D. (One way anova followed by 
Dunnett's test). 
 
 
 
 
 
 
 38 
0
1
2
3
4
5
6
Liver (g) Heart (g) Lung (g) Spleen (g) Ovary (g) Testes (g) Brain (g) Kidney (g) Stomach
(g)
Control Group 1 Group II Group III
 39
 
 
 
 
Changes in brain 
 
Oedema 
 
Asterocytic proliferation 
 
Degenerative changes  (nural fibre damage) 
 
 
 
 
 
 
 
 
 
 
CONTROL GROUP BRAIN HIGH DOSE 
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Changes  in  Heart   
  
No  Changes  (Normal) 
 
 
 
 
 
 
CONTROL GROUP HEART HIGH  DOSE 
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Changes  in  Lung 
 
Interstitial  Fibrosis 
 
Emphysematous  changes  
 
 
 
CONTROL GROUP LUNG HIGH DOSE 
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CONTROL GROUP LIVER HIGH  DOSE 
 
 
 
 
Changes  in Liver 
 
Inflammatory  cells around  portal triad 
 
Hepatocytes  show  condensed  nucleus 
 
Congested  vessels 
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Changes  in  Kidney 
 
Marked  tubular  necrosis 
 
Haemorrhage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONTROL GROUP KIDNEY HIGH DOSE 
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Changes in Stomach 
 
Congesion  and erosion  superficially. 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONTROL GROUP STOMACH HIGH  DOSE 
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Changes  in Spleen 
 
No Changes  (Normal). 
 
 
 
 
 
 
CONTROL GROUP SPLEEN HIGH DOSE 
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CONTROL GROUP TESTES  HIGH  DOSE 
 
 
 
 
 
Changes  in Testes 
 
No Changes  (Normal). 
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CONTROL GROUP OVARY HIGH  DOSE 
 
 
 
 
 
Changes  in Ovary 
 
No Changes  (Normal). 
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DISCUSSION 
In this study Veera Chenduram was analyzed in chemical and 
toxicological aspects.   
 
The results of acute and sub acute toxicity study revealed that the 
treatment of veera chenduram on rats possess significant changes in general 
behavioural pattern and produced major signs of toxicity from the dose level 
of 500mg/kg and above in an acute exposure. The animals showed changes 
in general behaviour other physiological activities like giddiness, sniffing, 
aggressiveness, tachypnoea, convulsion finally at the dose level of 1g/kg.  
 
In the sub acute toxicity study, after 28 days of alternate day treatment 
of veera chenduram in single oral dose showed insignificant body weight 
changes (Table-1) during the experimental period. But significant (P<0.01) 
increase in food intake was observed in all the groups after one week of drug 
treatment (Table-2). There was a gradual decrease in water consumption was 
observed in all the groups throughout the study period (Table-3). 
 
In the haematological parameters, there was a marked increase in TLC 
and RDW was observed (Table-4). 
Similarly, from the biochemical analysis, the ALP, SGOT, SGPT levels 
were decreased significantly (P<0.01)in all the dose treated groups but there 
was no major modifications in the other biochemical parameters. A fall of 
blood glucose level was observed in the groups treated with 50mg/kg dose of 
veera chenduram (Table-5). 
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Table-6 shows that the urea, sodium concentrations are drastically 
increased (P<0.01) in all the dose treated groups with respect to control. 
There was no effect on total cholestrol. The results of urine analysis indicates 
that the urine volume is gradually decreased in the dose dependent manner 
after veera chenduram treatment. In the same manner there was a slight 
alterations was observed in PH. The colour intensity of the urine is increased 
on the basis of drug dose range. In the urine collected from the 200mg/kg 
veera chenduram treated group few RBC, Pus and epithelial cells were seen 
(Table-8). The isolated vital organ weights were changed significantly after 28 
days of veera chenduram treatment in experimental animals. Particularly, 
liver, lung, spleen and stomach weights were decreased (Table-9). 
  
In histopathological studies the brain and kidney were mostly affected.  
Stomach shows superficial erosion.  
  
So, based on the results it can be concluded that the veera chenduram 
falls under the category of drug with high toxicity and it can be suggested that 
the use of veera chenduram clinically for long term therapy may cause severe 
toxic symptoms like liver damage, respiratory ailments and impotence in 
females. Therefore in conclusion   this study presents strong evidence of the 
toxic effect of the Veera chenduram. These results showed that the use of the 
Veera chenduram is not safe and suitable for the extensive utilization or for 
longterm therapy even at the dose level of 50mg/kg clinically.   
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SUMMARY 
Veera Chenduram a widely used Siddha medicine contains mercuric 
chloride. This is used for the treatment of several ailments.  
  Veeram  purchased from local market. The drug was prepared as per 
Siddha literature. First the prepared drug was studied electrochemical 
analysis (XRD) studies.  
After the chemical study the test drug were studied for toxicity. During 
the acute toxicity study the animals fasted overnight were given single oral 
dose of Veera Chenduram (5 to 2000mg /kg body wt) suspended in water. 
Animals of the control group received only water (2ml). Death was recorded 
during the treatment period in treated groups given 1kg/ kg of Veera 
Chenduram orally.  The treatment of Veera chenduram on rats possess 
significant changes in general behavioral pattern and produced major signs of 
toxicity from the dose level of 500mg /kg and above in an acute exposure. 
The sub acute toxicity was studied in 28 days as per OECD Guidelines 
407.  During the period of administration the animals were weighed and food 
and water intake were monitored. After 28 days all surviving animals were 
fasted overnight and collected 24 hours urine. Animals were sacrificed by 
decapitation and blood samples were collected for lab investigation. The 
Brain, Lung, Liver, Pancreas, Spleen, Stomach Testes, Ovary, Heart and 
Kidney were collected and weighed. Histo pathological examinations of the 
tissue samples were taken from these organs. The treated rats revealed some 
pathological lesions. The brain and kidneys were mostly affected. 
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CONCLUSION 
 
 In conclusion, these findings suggest that the Veera Chenduram is 
practically toxic or lethal after an acute exposure at the dose level of 1g/kg. 
The Veera Chenduram affects almost all the vital organs at the maximum 
dose range of 200mg/kg. The normal human dose is very minimal to compare 
the study group doses. If given the test drug as per literature do not produce 
toxicity. Hence, to avoid the major adverse reactions the duration of treatment 
is minimized.  
 Because of an ideal man of 70 k.g. body weight requires 4mg of the 
drug two times daily.  But rats body weight are approximately 100 – 120gms.  
We have given 50mg /kg, 100mg/kg, 200mg/kg daily.  These doses are more 
than human dose.  So we can come to conclusion that the drug was in normal 
dose it might not produce any pathological changes. 
 The aim of giving such a high dose was to find out the type of toxicity if 
the drug was given in abnormal high dose.  This toxicity due to overdose 
could occur in a patient, if proper dose is not prescribed by the physician or 
followed by the patient. 
 So the recommended human dose may not produce any ill effects and 
this must be proved by further animal studies and also by clinical studies by 
volunteers.  This dissertation work is the first step for continuous research in 
this title. 
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